333 related articles for article (PubMed ID: 10430612)
1. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
Chiang N; Gronert K; Clish CB; O'Brien JA; Freeman MW; Serhan CN
J Clin Invest; 1999 Aug; 104(3):309-16. PubMed ID: 10430612
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
[TBL] [Abstract][Full Text] [Related]
4. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
5. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.
Devchand PR; Arita M; Hong S; Bannenberg G; Moussignac RL; Gronert K; Serhan CN
FASEB J; 2003 Apr; 17(6):652-9. PubMed ID: 12665478
[TBL] [Abstract][Full Text] [Related]
6. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
[TBL] [Abstract][Full Text] [Related]
7. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation.
Chiang N; Fierro IM; Gronert K; Serhan CN
J Exp Med; 2000 Apr; 191(7):1197-208. PubMed ID: 10748237
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
9. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
Serhan CN
Arch Immunol Ther Exp (Warsz); 2001; 49(3):177-88. PubMed ID: 11478391
[TBL] [Abstract][Full Text] [Related]
10. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
11. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
Pouliot M; Serhan CN
J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363
[TBL] [Abstract][Full Text] [Related]
12. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
Papayianni A; Serhan CN; Brady HR
J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
[TBL] [Abstract][Full Text] [Related]
13. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?
Serhan CN
Prostaglandins; 1997 Feb; 53(2):107-37. PubMed ID: 9112289
[TBL] [Abstract][Full Text] [Related]
14. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils.
Qiu FH; Devchand PR; Wada K; Serhan CN
FASEB J; 2001 Dec; 15(14):2736-8. PubMed ID: 11687510
[TBL] [Abstract][Full Text] [Related]
15. Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.
Clària J; Titos E; Jiménez W; Ros J; Ginès P; Arroyo V; Rivera F; Rodés J
Gastroenterology; 1998 Jul; 115(1):147-56. PubMed ID: 9649470
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
Clària J; Lee MH; Serhan CN
Mol Med; 1996 Sep; 2(5):583-96. PubMed ID: 8898374
[TBL] [Abstract][Full Text] [Related]
17. Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability.
Serhan CN; Takano T; Clish CB; Gronert K; Petasis N
Adv Exp Med Biol; 1999; 469():287-93. PubMed ID: 10667343
[No Abstract] [Full Text] [Related]
18. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.
Pouliot M; Clish CB; Petasis NA; Van Dyke TE; Serhan CN
Biochemistry; 2000 Apr; 39(16):4761-8. PubMed ID: 10769133
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
Chiang N; Arita M; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
[TBL] [Abstract][Full Text] [Related]
20. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin.
Fiorucci S; Distrutti E; de Lima OM; Romano M; Mencarelli A; Barbanti M; Palazzini E; Morelli A; Wallace JL
FASEB J; 2003 Jun; 17(9):1171-3. PubMed ID: 12709408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
